Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Study on the Capacity of the IGF-1 Stimulation Test to Predict the Growth Promoting Effect of Standard and High Doses of Genotonorm® in Prepubertal Children With Growth Hormone Deficiency.

NCT00145457 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00145457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00145457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Study on the Capacity of the IGF-1 Stimulation Test to Predict the Growth Promoting Effect of Standard and High Doses of Genotonorm® in Prepubertal Children With Growth Hormone Deficiency.
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2001
Completion date
January 31, 2005
Enrollment
82
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency